4//SEC Filing
John Anish M. 4
Accession 0001493152-23-001942
CIK 0001642380other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:14 PM ET
Size
5.5 KB
Accession
0001493152-23-001942
Insider Transaction Report
Form 4
John Anish M.
SVP, Finance, and Interim CFO
Transactions
- Award
Option to Purchase Common Stock
2023-01-17+250,466→ 250,466 totalExercise: $0.46Exp: 2033-01-17→ Common Stock (250,466 underlying)
Footnotes (1)
- [F1]The options will become exercisable in three equal installments on each of January 17, 2024, January 17, 2025 and January 17, 2026, subject to continuous service through the applicable vesting date.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001933248
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 5:14 PM ET
- Size
- 5.5 KB